CIK: 0001582844 · Show all filings
Period: Q1 2019 (← Previous) (Next →)
Filing Date: May 14, 2019
Total Value ($000): $210,309 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 2,944,201 | $27,999 | 13.3% | $7.92 | +22.7% | COM | 462260100 |
| — | KADMON HLDGS INC | 7,635,000 | $20,156 | 9.6% | $3.68 | — | COM | 48283N106 |
| — | ASSEMBLY BIOSCIENCES INC | 760,500 | $14,974 | 7.1% | $16.58 | — | COM | 045396108 |
| — | CAS MED SYS INC | 5,263,508 | $12,790 | 6.1% | $1.45 | — | COM PAR | 124769209 |
| INSM | INSMED INC | 370,000 | $10,756 | 5.1% | $25.92 | 0.0% | COM PAR $.01 | 457669307 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 206,000 | $10,603 | 5.0% | $39.91 | — | COM | G11196105 |
| — | IMMUNOMEDICS INC | 500,000 | $9,605 | 4.6% | $13.68 | — | COM | 452907108 |
| VCYT | VERACYTE INC | 381,500 | $9,545 | 4.5% | $7.25 | +163.5% | COM | 92337F107 |
| — | DERMIRA INC | 636,500 | $8,625 | 4.1% | $13.55 | — | COM | 24983L104 |
| ARGX | ARGENX SE | 63,500 | $7,927 | 3.8% | $61.18 | — | SPONSORED ADR | 04016X101 |
| — | CYMABAY THERAPEUTICS INC | 517,500 | $6,872 | 3.3% | $13.28 | — | COM | 23257D103 |
| VRAYQ | VIEWRAY INC | 815,000 | $6,023 | 2.9% | $7.19 | +7.2% | COM | 92672L107 |
| KALV | KALVISTA PHARMACEUTICALS INC | 205,500 | $5,881 | 2.8% | $16.22 | +33.6% | COM | 483497103 |
| ENTA | ENANTA PHARMACEUTICALS INC | 61,000 | $5,827 | 2.8% | $89.70 | 0.0% | COM | 29251M106 |
| XENE | XENON PHARMACEUTICALS INC | 552,500 | $5,613 | 2.7% | $6.86 | +23.6% | COM | 98420N105 |
| IRIX | IRIDEX CORP | 1,174,500 | $5,356 | 2.5% | $11.40 | -59.4% | COM | 462684101 |
| — | DICERNA PHARMACEUTICALS INC | 328,825 | $4,817 | 2.3% | $14.65 | — | COM | 253031108 |
| — | ADVERUM BIOTECHNOLOGIES INC | 919,000 | $4,816 | 2.3% | $5.24 | — | COM | 00773U108 |
| ARVN | ARVINAS INC | 314,000 | $4,635 | 2.2% | $17.74 | 0.0% | COM | 04335A105 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 337,500 | $4,242 | 2.0% | $8.83 | 0.0% | COM | 74366E102 |
| ALEC | ALECTOR INC | 200,000 | $3,744 | 1.8% | $18.92 | 0.0% | COM | 014442107 |
| — | ACER THERAPEUTICS INC | 147,000 | $3,572 | 1.7% | $21.33 | — | COM | 00444P108 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 167,500 | $3,074 | 1.5% | $16.50 | 0.0% | COM | 04280A100 |
| — | MIRATI THERAPEUTICS INC | 41,000 | $3,005 | 1.4% | $73.29 | — | COM | 60468T105 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 50,000 | $2,574 | 1.2% | $39.91 | — | Call | G11196105 |
| — | QUOTIENT LTD | 280,000 | $2,523 | 1.2% | $9.01 | — | SHS | G73268107 |
| — | AMARIN CORP PLC | 87,500 | $1,817 | 0.9% | $14.04 | — | SPONS ADR NEW | 023111206 |
| GOSS | GOSSAMER BIO INC | 60,000 | $1,300 | 0.6% | $20.85 | 0.0% | COM | 38341P102 |
| — | ALLAKOS INC | 13,500 | $547 | 0.3% | $40.52 | — | COM | 01671P100 |
| — | SUTRO BIOPHARMA INC | 45,500 | $518 | 0.2% | $9.01 | — | COM | 869367102 |
| — | CHEMBIO DIAGNOSTICS INC | 41,667 | $231 | 0.1% | $7.05 | — | COM NEW | 163572209 |
| BCRX | BIOCRYST PHARMACEUTICALS | 25,000 | $204 | 0.1% | $7.78 | +10.1% | COM | 09058V103 |
| — | NOVAVAX INC | 250,000 | $138 | 0.1% | — | — | Put | 670002104 |